VIDAI

VIDAI is an innovative and AI- Powered EMR solution, is fully acquired by Progenesis INC, USA and is the first company in US to introduce Next Generation Sequencing (NGS) for Preimplantation Genetic Testing for Aneuploidy (PGT-A) and Preimplantation Genetic Testing for Monogenic disorders (PGT-M). With this acquisition we opens up new opportunities for us to elevate our offerings and bring even more value to your projects. VIDAI is a advanced Operating System tailored specifically for fertility clinics. With a bold vision to transform the healthcare industry, VIDAI harnesses the immense potential of AI and automation. Its state-of-the-art Software-as-a-Service (SaaS) offering represents a pinnacle of technological advancement, seamlessly optimizing clinic operations, elevating data management practices, and ultimately enhancing both patient outcomes and overall clinic performance. By streamlining processes and leveraging cutting-edge capabilities